Abstract
Background: We studied the effect of the calmodulin antagonist trifluoperazine (TFP) on isolated
intact rat tracheal and pulmonary artery smooth muscle contractile behaviour. Methods: Experimental series: 1) TFP-dose-response curves for TFP's effect on force generation
were constructed using rat tracheal smooth muscles and rat pulmonary artery preparations
(n = 8). A concentration of 1 µmol/l TFP was chosen for the subsequent experimental
series. 2) Tracheas and pulmonary arteries (n = 14) were dissected in three segments.
One of them was used immediately for experiments (“native”), the other two were treated
for 12 h in 4 °C Tyrode solution without (“12 h cold storage”) or with 1 µmol/l TFP
(“12 h cold storage + TFP”). These preparations contracted after supramaximal effective
electrical field stimulation. The force-clamping technique was used to analyse kinetic
and mechanical parameters of smooth-muscle contraction in both types of preparation
(measurement conditions: resting tension 2 mN, 37 °C, modified Krebs-Henseleit solution).
Results: 1) TFP decreased developed force dose-dependently in pulmonary artery and tracheal
smooth muscle. 2) During sustained tonic activation, the contraction kinetics become
slower both with and without TFP treatment (p < 0.0001). 3) TFP caused a dramatic
retardation of the velocity of force generation in both types of preparation for any
given time interval during the course of a tonic activation (p < 0.0005). 4) The dramatic
effects of TFP on the contraction kinetics were not associated with effects on the
extent of force generation. Conclusions: These results support the assumption that tracheal and pulmonary artery smooth muscle
cross-bridge rates are controlled by a calcium-calmodulin-dependent myosin light chain
kinase. This finding suggests the involvement of a calmodulin-independent regulator
process responsible for the changes observed in the cross-bridge cycling rates during
sustained tonic activation. A direct intervention on the contractile apparatus level
is a measure for reduction of smooth-muscle tone without negative inotropic side effects.
Key words
Calmodulin - Contraction kinetics - Cross-bridge cycling - Rat smooth muscle - Trifluoperazine
References
- 1
Aksoy M O, Murphy R A, Kamm K E.
Role of Ca2+ and myosin light chain phosphorylation in regulation of smooth muscle.
Am J Physiol.
1982;
242
C109-116
- 2
Gerthoffer W T, Yamboliev I A, Pohl J, Haynes R, Dang S, Me Hugh J.
Activation of MAP kinases in airway smooth muscle.
Am J Physiol.
1997;
272
L244-252
- 3
Gerthoffer W T, Murphy R A.
Myosin phosphorylation and regulation of cross-bridge cycle ian tracheal smooth muscle.
Am J Physiol.
1983;
C
182-187
- 4
Kai T, Yoshimura H, Jones K A, Warner D O.
Relationship between force and regulatory myosin light chain phosphorylation in airway
smooth muscle.
Am J Physiol.
2000;
279
52-58
- 5
Sobieszek A.
Enzyme kinetic characterisation of the smooth muscle myosin phosphorylating system:
activation by calcium and calmodulin and possible inhibitory mechanisms of antagonists.
Biochim et Biophys Acta.
1999;
1450
77-91
- 6
Watanabe H, Takahashi R, Zhang X, et al.
An essential role of myosin light-chain kinase in the regulation of agonist- and fluid
flow-stimulated Ca2+ influx in endothelial cells.
FASEB.
1998;
12
(3)
341-348
- 7 Seeger W, Olschewski H, Grimminger F.
Physiologie und Pathophysiologie der pulmonalen Hypertension. In: Schäfers HJ, Seeger W (Hrsg) Pulmonale Hypertonie. Berlin, Wien, Oxford; Blackwell
2001: 1-19
- 8
Tiefenbacher C P, Bleeke T, Vahl C, Amann K, Vogt A, Kübler W.
Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin
in atherosclerosis.
Circ .
2000;
102
2172-2179
- 9
Droogmans G, Raeymaekers L, Casteels R.
Electro- and pharmacomechanical coupling in the smooth muscle cells of the rabbit
ear artery.
J Glen Physiol.
1977;
70
129-148
- 10
Morgan J P, Morgan K G.
Stimulus specific patterns of the intracellular calcium levels in smooth muscle of
ferret portal vein.
J Physiol.
1984;
351
155-169
- 11
Morgan J P, Morgan K G.
Alteration of the cytoplasmic ionized Calcium levels in smooth muscle by vasodilators
in the ferret.
J Physiol.
1984;
357
539-551
- 12
Cauvin C R, Loutzenhiser R, van Breemen C.
Mechanisms of Calcium antagonist induced vasodilation.
Ann Rev Pharmacol Toxicol.
1983;
23
373-396
- 13
Cassidy P, Hoar P E, Kerrick W GL.
Inhibition of Ca2+-activated tension and myosin light chain phosphorylation in skinned smooth muscle
strips by phenothiazines.
Pflugers Arch.
1980;
387
115-120
- 14
Johnson J D, Fugman D A.
Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary
artery segments.
J Pharmacol Exp Thera.
1983;
226
330-334
- 15
Klemt P, Peiper U, Speden N, Zilker F.
The kinetics of post vibration tension recovery of the isolated rat portal vein.
J Physiol (London).
1981;
312
281-296
- 16
Peiper U, Vahl C F, Donker E.
The time cours eof changes in contraction kinetics during the tonic activation of
the rat tracheal smooth muscle.
Pflugers Arch.
1984;
402
83-87
- 17
Vahl C F, Bauernschmitt R, Bonz A, et al.
Increased resistance against shortening in myocardium from recipient hearts of 7 patients
transplanted for dilated cardiomyopathy.
Thorac cardiovasc Surg.
1993;
41
224-232
- 18
Norwood N, Moore T M, Dean D A, Bhattacherjee R, Li M, Stevens T.
Store-operated calcium entry and increased endothelial cell permeability.
Am J Physiol.
2000;
279
815-824
- 19
Matthew J D, Khromov A S, Trybus K M, Somlyo A P, Somlyo A V.
Myosin essential light chain isoforms modulate the velocity of shortening propelled
by nonphosphorylated cross-bridges.
J Biol Chem.
1998;
273
(47)
31289-31296
- 20
Peiper U, Vahl C F, Donker E, Buchholz D, Schreiber S.
The temperature dependency of post vibration tension recovery in intact and skinned
rat tracheal smooth muscle.
J Muscle Res Cell Mot.
1986;
7
33-338
Dr. N. Kayhan
Labor Herzchirurgie
Im Neuenheimer Feld 326
69120 Heidelberg
Germany
Phone: + 49-6221-566246
Fax: + 49-6221-429987
Email: kayhan.nalan@web.de